The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the identification of suitable chemical starting points for drug discovery programs. The physicochemical properties of molecules are crucial in determining the success of small molecules in clinical development, yet reports suggest that pharmaceutical and academic sectors often produce molecules with poor drug-like properties. We present a platform to design novel, high quality and diverse fragment- and lead-oriented libraries with appropriate physicochemical properties in a cost-efficient manner. This approach has the potential to assist the way libraries are constructed by significantly addressing the historical uneven exploration of chemical s...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
Natural products (NPs) are an excellent source of biologically active molecules that provide many bi...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
Synthesising polar semi-saturated bicyclic heterocycles can lead to better starting points for fragm...
In fragment-based drug discovery (FBDD), there is a developing appreciation that 3D fragments could ...
With the growth in fragment-based drug discovery, numerous strategies have been described for the de...
An innovative and efficient reagent- and scaffold-based diversity oriented synthesis (DOS) of a frag...
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug...
This book presents a company-based view of the recent progresses in fragment-based drug discovery (F...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
Natural products (NPs) are an excellent source of biologically active molecules that provide many bi...
The availability of suitable diverse fragment- and lead-oriented screening compounds is key for the ...
Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical pro...
Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficien...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
The first step in hit optimisation is the identification of the pharmacophore, which is normally ach...
Synthesising polar semi-saturated bicyclic heterocycles can lead to better starting points for fragm...
In fragment-based drug discovery (FBDD), there is a developing appreciation that 3D fragments could ...
With the growth in fragment-based drug discovery, numerous strategies have been described for the de...
An innovative and efficient reagent- and scaffold-based diversity oriented synthesis (DOS) of a frag...
Optimisation of the affinity of lead compounds is a critical challenge in the identification of drug...
This book presents a company-based view of the recent progresses in fragment-based drug discovery (F...
Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated f...
Fragment-based drug discovery (FBDD) is a well-established approach for the discovery of novel medic...
Natural products (NPs) are an excellent source of biologically active molecules that provide many bi...